Inventor
TICHENOR MARK S
US25 patents
⚠️ This page may combine multiple inventors who share the name “TICHENOR MARK S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
21 patentsUS11059823B2Jul 13, 2021
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV4 citations83
US10981911B2Apr 20, 2021
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV6 citations83
US10487083B2Nov 26, 2019
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV7 citations83
US10364246B2Jul 30, 2019
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV7 citations83
US10294226B2May 21, 2019
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV11 citations83
US10717745B2Jul 21, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV5 citations82
US12065446B2Aug 20, 2024
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV1 citations72
US11827638B2Nov 28, 2023
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV2 citations72
US11319329B2May 3, 2022
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV1 citations72
US11066406B2Jul 20, 2021
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV3 citations72
US8952177B2Feb 10, 2015
1,2,6-substituted benzimidazoles as FLAP modulators
JANSSEN PHARMACEUTICA NV4 citations72
US10934310B2Mar 2, 2021
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV4 citations71
US12202831B2Jan 21, 2025
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV0 citations62
US9089569B2Jul 28, 2015
1,2,6-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV3 citations62
US11787807B2Oct 17, 2023
Small molecule inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV0 citations61
US9695149B2Jul 4, 2017
1,2,6-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV0 citations51
US10822348B2Nov 3, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10800792B2Oct 13, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10689396B2Jun 23, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US8877769B2Nov 4, 2014
Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
JANSSEN PHARMACEUTICA NV0 citations48
US10172856B2Jan 8, 2019
2,4-diaminopyrimidine derivatives as histamine H4 modulators
JANSSEN PHARMACEUTICA NV0 citations41
BREITENBUCHER J GUY
3 patentsUS8901111B2Dec 2, 2014
Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
BREITENBUCHER J GUY3 citations60
US8598356B2Dec 3, 2013
Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
BREITENBUCHER J GUY4 citations59
US8461159B2Jun 11, 2013
Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
BREITENBUCHER J GUY4 citations59